PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Treatment for opioid use disorder rises after Medicare OKs methadone coverage

Evidence suggests change created new treatment rather than displacing use of other medications

2023-05-19
(Press-News.org) The use of methadone among Medicare beneficiaries to treat opioid use disorder increased sharply after the program began covering the drug, with evidence suggesting the change created new treatment rather than displacing use of other medications, according to a new RAND Corporation study.

 

Studying a large group of Medicare Advantage enrollees, the study found that a Medicare coverage expansion to include methadone in 2020 did not appear to reduce the use of buprenorphine, another medication used to treat opioid use disorder.

 

The study, published in the journal JAMA Network Open, found that much of the rise in methadone use was among Medicare Advantage enrollees who are younger than 65, particularly among those who qualify for both Medicare and Medicaid.

 

“These new policies represent an important step in increasing access to medication treatment for opioid use disorder for Medicare beneficiaries,” said Erin Taylor, the study’s lead author and a senior policy researcher at RAND, a nonprofit research organization.

 

The nation’s opioid crisis resulted in more than 80,000 overdose deaths in 2021. Using medication to treat opioid use disorder is an effective form of care for people facing the problem.

 

Buprenorphine and naltrexone are medications that can be prescribed by physicians and taken at home to treat opioid use disorder. In contrast, the medication methadone typically is only  dispensed to patients through federally certified and licensed opioid treatment programs.

 

In January 2020, Medicare expanded payment for treating opioid use disorder to include methadone for the first time. In addition, rules were adopted in March 2020 in response to the COVID-19 pandemic to facilitate access to medication treatment for opioid use disorder, including take-home methadone.

 

To examine the effects that the changes had on use of opioid treatment drugs among Medicare recipients, RAND researchers examined encounter data and pharmacy records from a large commercial dataset of nearly 10 million people enrolled in Medicare Advantage health plans.

 

About half of Medicare recipients are enrolled in Medicare Advantage, which are private health plans that typically provide more benefits to enrollees than Medicare fee-for-service, but may limit services to a smaller set of providers.

 

Researchers found that the implementation of the Medicare coverage change, as well as policies designed to increase access to opioid use disorder treatment during the pandemic, appeared to be associated with increasing rates of methadone use among Medicare Advantage enrollees in each quarter beginning in January 2020.

 

The rate of use of buprenorphine also increased among Medicare Advantage enrollees during the study period. As with methadone, rates of use of buprenorphine among Medicare Advantage enrollees was higher among those who were younger than 65.

 

“We found a relatively steady rate of increase in buprenorphine prescribing, which showed no obvious changes after coverage for methadone began,” Taylor said. “This suggests that there was little substituting of methadone for buprenorphine.”

 

Researchers were unable to assess whether some of the Medicare Advantage enrollees who received methadone under the new policies previously may have received treatment paid for by alternative means, such as block grant programs.

 

They say future work should explore reasons for the differential increases in methadone use among Medicare Advantage enrollees by dual eligibility status and by age, as well as whether there have been increases in methadone use among beneficiaries enrolled in traditional fee-for-service Medicare.

 

Support for the study was provided by the National Institute on Aging.

 

Other authors of the study are Jonathan H. Cantor and Bradley D. Stein, both of RAND, and Ashley C. Bradford and Kosali Simon, both of Indiana University

 

RAND Health Care promotes healthier societies by improving health care systems in the United States and other countries.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Illinois Tech researchers unveil key predictors of bitcoin returns

Illinois Tech researchers unveil key predictors of bitcoin returns
2023-05-19
CHICAGO—May 19, 2023—Blockchain technology, investor sentiment, and economic stress levels are significant predictors of bitcoin returns, according to a groundbreaking paper from Illinois Institute of Technology researchers that provides empirical evidence to help guide investors, economists, and academics. Sang Baum “Solomon” Kang, associate professor of finance at Illinois Tech’s Stuart School of Business and co-author of the paper, also found that the cryptocurrency is detached from economic fundamentals and therefore may not effectively serve as a diversifier or safe-haven asset. Additionally, Kang reported that returns on commodities, ...

SCAI announces second cycle recipients of Early Career Research Grants

2023-05-19
PHOENIX (May 19, 2023) – Today, the Society for Cardiovascular Angiography & Interventions (SCAI) announced the recipients of the second cycle of Early Career Research Grants, an initiative offered by SCAI to support the next generation of interventional cardiologists in advancing their research careers. The second cycle recipients were presented during the Early Career Award Presentations at the SCAI 2023 Scientific Sessions in Phoenix. The Early Career Research Grants provide a platform for junior-level investigators who are within ten years of completing an interventional cardiology fellowship to study high-priority, clinically ...

New study shows noninvasive brain imaging can distinguish among hand gestures

New study shows noninvasive brain imaging can distinguish among hand gestures
2023-05-19
LA JOLLA, CA, May 19, 2023 — Researchers from University of California San Diego have found a way to distinguish among hand gestures that people are making by examining only data from noninvasive brain imaging, without information from the hands themselves. The results are an early step in developing a non-invasive brain-computer interface that may one day allow patients with paralysis, amputated limbs or other physical challenges to use their mind to control a device that assists with everyday tasks. The research, recently published online ahead of print in the journal Cerebral Cortex, represents the best results thus far in distinguishing single-hand ...

Ticogrelor monotherapy post PCI associated with similar rates of revascularization as duel antiplatelet therapy

2023-05-19
Phoenix, AZ (May 19, 2023)- New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar rates of recurrent coronary revascularization, major adverse cardiac and cerebrovascular events (MACCE) and a lower risk of net adverse clinical events (NACE) compared with duel antiplatelet therapy (DAPT). The results from the randomized control trial of more than 7,000 patients were presented today as late-breaking clinical research at ...

An innovative machine-learning program reveals genes responsible for sex-specific differences in Alzheimer's disease progression

2023-05-19
Alzheimer's Disease (AD) is a complex neurodegenerative illness with genetic and environmental origins. Females experience faster cognitive decline and cerebral atrophy than males, while males have greater mortality rates. Using a new machine-learning method they developed called ‘Evolutionary Action Machine Learning (EAML)’, researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital have discovered sex-specific genes and molecular pathways that contribute to the development and progression of this condition. The study was published in Nature Communications. “We ...

Targeting cellular respiration as a therapeutic strategy in glioblastoma

Targeting cellular respiration as a therapeutic strategy in glioblastoma
2023-05-19
BUFFALO, NY- May 19, 2023 – A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, “Targeting cellular respiration as a therapeutic strategy in glioblastoma.” While glycolysis is abundant in malignancies, mitochondrial metabolism is significant as well. Mitochondria harbor the enzymes relevant for cellular respiration, which is a critical pathway for both regeneration of reduction equivalents and energy production in the form of ATP. In this research perspective, researchers Enyuan Shang, Trang Thi Thu Nguyen, Mike-Andrew Westhoff, Georg Karpel-Massler, and Markus ...

Why do so many businesses fail? A new study suggests it has to do with when they're born

2023-05-19
Only 25% of new businesses make it to 15 years or more, according to data from the U.S. Bureau of Labor and Statistics. Despite vacillating economic conditions between and across markets, that statistic has remained consistent for 30 years. A new study from the Strategic Entrepreneurship Journal suggests an elegant explanation: a business’s long-term success  depends significantly on its founding conditions not just changes in its markets. “A venture’s performance following environmental change depends on its internal ...

Blinding idea evaluation? New experiment reveals little bias in the innovation process

2023-05-19
Innovation and implementation of new ideas can directly influence organizational outcomes. Thus, organizations often dedicate significant time to the assessment of countless new ideas through myriad idea evaluation systems. However, the evaluation process is often distorted by various biases arising from hierarchy, sequence, and nepotism. Data on evaluation studies show that evaluators can be biased toward specific idea proposers. In a new study published in the Strategic Management Journal, a research team sought evidence for the bias claim by employing a blinding approach for evaluating ...

Novel approach that stimulates cells’ DNA repair mechanisms may combat a leading cause of autism spectrum disorders

2023-05-19
Key Takeaways Researchers have discovered that stimulating cells’ DNA repair mechanisms may correct the inherited genetic defect that defines fragile X syndrome, a leading cause of autism spectrum disorders. The method involves enhanced production of special nucleic acid structures called “R-loops” that cells see as DNA damage. BOSTON – New research has identified a potential method for treating fragile X syndrome, a leading cause of autism spectrum disorders that is characterized ...

UAF scientists to hunt for clues about Arctic Ocean glaciation

2023-05-19
Evidence indicates a thick ice sheet, not annual sea ice and icebergs, covered the Arctic Ocean at some point during the last 140,000 years. Now, University of Alaska Fairbanks scientists will be looking for more geologic proof of the ice sheet’s existence, sources, behavior and extent. UAF Geophysical Institute scientists will focus on the Beaufort and Chukchi seas region, both offshore and onshore.  They hope to discover the extent of glaciation and improve understanding of the timing of glacial advances and retreats. Those cycles are thought to have occurred approximately 140,000 to 70,000 years ago, a period known as the ...

LAST 30 PRESS RELEASES:

USC researchers observe mice may have a form of first aid

VUMC to develop AI technology for therapeutic antibody discovery

Unlocking the hidden proteome: The role of coding circular RNA in cancer

Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC

Study reveals widening heart disease disparities in the US

The role of ubiquitination in cancer stem cell regulation

New insights into LSD1: a key regulator in disease pathogenesis

Vanderbilt lung transplant establishes new record

Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine

Metasurface technology offers a compact way to generate multiphoton entanglement

Effort seeks to increase cancer-gene testing in primary care

Acoustofluidics-based method facilitates intracellular nanoparticle delivery

Sulfur bacteria team up to break down organic substances in the seabed

Stretching spider silk makes it stronger

Earth's orbital rhythms link timing of giant eruptions and climate change

Ammonia build-up kills liver cells but can be prevented using existing drug

New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock

Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza

New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance

nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip

Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure

Fluoride in drinking water is associated with impaired childhood cognition

New composite structure boosts polypropylene’s low-temperature toughness

While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains

Revolutionizing surface science: Visualization of local dielectric properties of surfaces

LearningEMS: A new framework for electric vehicle energy management

Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction

The changing chorus: How movements and memories influence birdsong evolution

One in 15 U.S. adults have been on the scene of a mass shooting

Prevalence of depression and anxiety among adults with chronic pain

[Press-News.org] Treatment for opioid use disorder rises after Medicare OKs methadone coverage
Evidence suggests change created new treatment rather than displacing use of other medications